Enjoy complimentary customisation on priority with our Enterprise License!
The stem cell umbilical cord blood (UCB) market size is forecast to increase by USD 1.69 billion at a CAGR of 18.5% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of metabolic disorders and the rising demand for advanced transplant medicine. The investment in regenerative medicine is surging, leading to increased research and development in UCB applications. However, the market faces challenges such as high operational costs, including testing and storage in specialized facilities. These facilities ensure the safety and efficacy of the UCB, which is crucial for successful transplantation. The report provides an in-depth analysis of these trends and challenges, offering insights into the market's future growth prospects.
_Market_size_abstract_2024_v1.jpg.webp?v4.1.20)
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.